Cargando…
Elevated Levels of Peripheral Kynurenine Decrease Bone Strength in Rats with Chronic Kidney Disease
The diagnosis and treatment of bone disorders in patients with chronic kidney disease (CKD) represent a clinical challenge. CKD leads to mineral and bone complications starting early in the course of renal failure. Recently, we have observed the positive relationship between intensified central kynu...
Autores principales: | Kalaska, Bartlomiej, Pawlak, Krystyna, Domaniewski, Tomasz, Oksztulska-Kolanek, Ewa, Znorko, Beata, Roszczenko, Alicja, Rogalska, Joanna, Brzoska, Malgorzata M., Lipowicz, Pawel, Doroszko, Michal, Pryczynicz, Anna, Pawlak, Dariusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671515/ https://www.ncbi.nlm.nih.gov/pubmed/29163188 http://dx.doi.org/10.3389/fphys.2017.00836 |
Ejemplares similares
-
A link between central kynurenine metabolism and bone strength in rats with chronic kidney disease
por: Kalaska, Bartlomiej, et al.
Publicado: (2017) -
The Association between Elevated Levels of Peripheral Serotonin and Its Metabolite – 5-Hydroxyindoleacetic Acid and Bone Strength and Metabolism in Growing Rats with Mild Experimental Chronic Kidney Disease
por: Pawlak, Dariusz, et al.
Publicado: (2016) -
Indoxyl Sulfate Promotes Arterial Thrombosis in Rat Model via Increased Levels of Complex TF/VII, PAI-1, Platelet Activation as Well as Decreased Contents of SIRT1 and SIRT3
por: Karbowska, Malgorzata, et al.
Publicado: (2018) -
Modulation of the Paracrine Kynurenic System in Bone as a New Regulator of Osteoblastogenesis and Bone Mineral Status in an Animal Model of Chronic Kidney Disease Treated with LP533401
por: Mor, Adrian, et al.
Publicado: (2020) -
Kynurenine Pathway in Chronic Kidney Disease: What’s Old, What’s New, and What’s Next?
por: Mor, Adrian, et al.
Publicado: (2020)